DIRS.INFO The most relevant business & tech news

☆ Moderna shifts focus to developing cancer vaccinations
▼ + stars: | 2022-12-19 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailModerna shifts focus to developing cancer vaccinationsMichael Yee of Jefferies joins 'Closing Bell' to discuss Moderna's shift away from Covid-focused pharmaceuticals toward PCV cancer vaccination, the market size for personalized cancer vaccines and the Moderna-Merck partnership.

☆ Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history
▼ + stars: | 2022-12-06 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. Pfizer has rejected allegations made by rival Moderna that its Covid-19 vaccine is a copy, accusing the Boston biotech company of rewriting history to lay claim to technology developed by a field of scientists over many years. Pfizer asked a federal court in Massachusetts on Monday to dismiss Moderna's lawsuit seeking monetary damages for alleged patent violations related to the Boston company's Covid vaccine. "The Moderna inventions that Pfizer and BioNTech chose to copy were foundational for the success of their vaccine," the company claimed. Pfizer and BioNTech did not copy Moderna's technology," Pfizer said in its response.

☆ British nurses to stage first strikes on Dec. 15, 20
▼ + stars: | 2022-11-25 | by ( ) www.reuters.com time to read: +2 min

Jacob King/Pool via REUTERS/File PhotoLONDON, Nov 25 (Reuters) - Thousands of British nurses will go on strike on Dec. 15 and 20 for more pay, their union said on Friday, adding to a winter of industrial action and putting further pressure on the state-run health system. The strikes are the first of possibly several walkouts by National Health Service (NHS) nurses, which come after the government refused to meet demands for pay rises of 5% above inflation. He said the NHS had plans in place to minimise any disruption from the strikes and ensure continuity for emergency services. "Why on Earth is the Health Secretary refusing to negotiate with nurses?" "Patients already can’t get treated on time, strike action is the last thing they need, yet the Government is letting this happen."

☆ Analysis: The final season of ‘Dead to Me’ is a poignant eulogy
▼ + stars: | 2022-11-19 | by ( Lisa Respers France | ) edition.cnn.com time to read: +6 min

Believe it or not, one of the things that has been helping me lately is just carving out some chill time. Three things to watch‘Dead to Me’ Season 3Christina Applegate as Jen Harding in a scene from "Dead to Me" on Netflix. Saeed Adyani/NetflixThe new season of “Dead to Me,” starring Christina Applegate and Linda Cardellini, will be the dark comedy series’ last. I am especially invested in this last season given Applegate’s revelation that she has multiple sclerosis. ‘The Santa Clauses’Tim Allen (second from right) in a scene from "The Santa Clauses" on Disney+.

☆ Moderna says Covid booster better against omicron BA.5, triggers immune response against BQ.1.1
▼ + stars: | 2022-11-14 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

Moderna's new Covid booster triggered a stronger immune response against omicron BA.5 and also appears to work against the emerging BQ.1.1 subvariant, according to the company. Moderna, in clinical trial data published Monday, found that the new booster triggered five times more antibodies against omicron BA.5 than the old vaccines in people with prior Covid infections. Moderna said it also found the new booster triggered robust immune response against omicron BQ.1.1, an emerging Covid subvariant in the U.S. Pfizer also released data earlier this month indicating that the boosters provide better protection against omicron BA.5 than the old shots. Two independent studies from Columbia and Harvard found that the boosters did not do a much better job against omicron BA.5.

In October 2021, Da’Vion Miller was found unconscious in the bathroom of his home in Detroit a week after receiving his first dose of Pfizer's Covid vaccine. Courtesy Da’Vion MillerMiller is one of a very small group of people in the United States who have experienced myocarditis following vaccination with the Pfizer-BioNTech or the Moderna Covid vaccines based on mRNA technology. Video: CDC says waiting longer between Covid vaccine doses could reduce myocarditis risk. Cooper joined an expert advisory panel formed by Moderna to monitor its Covid vaccine safety. The Pfizer study will include people who were previously hospitalized with vaccine-associated myocarditis, and it will also follow those who were more recently diagnosed.

☆ Moderna shares plummet after Covid vaccine maker lowers 2022 sales outlook
▼ + stars: | 2022-11-03 | by ( Spencer Kimball | ) www.cnbc.com time to read: +1 min

Moderna on Thursday lowered its 2022 sales guidance for its Covid-19 vaccine after missing Wall Street expectations for the third quarter. The Boston biotech company said it now expects to book $18 billion to $19 billion in revenue from its Covid vaccine this year, down from its previous guidance of $21 billion. Moderna said some Covid vaccine deliveries have been pushed into 2023 due to supply constraints. Moderna's third quarter revenue came in at $3.36 billion, down 32% from the same period in 2021. It is also expecting phase three immune response data from its flu vaccine candidate in the first quarter of 2023.

☆ Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patients
▼ + stars: | 2022-10-12 | by ( Spencer Kimball | ) www.cnbc.com time to read: +2 min

Moderna this week started testingModerna and Merck will jointly develop and sell a cancer vaccine that is personalized for individual patients, the companies announced on Wednesday. Moderna's vaccine, based on its messenger RNA technology, is being studied in combination with Merck's Keytruda to treat patients with high-risk melanoma, the deadliest form of skin cancer, in a phase 2 trial. Moderna's vaccine is designed to trigger the immune system to deploy killer T cells that target the specific mutations of a patient's tumors. The companies originally entered the agreement in 2016, but Merck is now exercising its option through a $250 million payment to Moderna. Moderna expects $21 billion in Covid vaccine sales this year as it rolls out new booster shots that target the omicron variant.

☆ Moderna to develop a personalized cancer vaccine with Merck
▼ + stars: | 2022-10-12 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailModerna to develop a personalized cancer vaccine with MerckMichael Yee, Jefferies managing director, joins 'Closing Bell' to share details on the Moderna and Merck announcement about a personalized cancer treatment for people with melanoma and what it means for Q3 earnings.

☆ Pfizer or Moderna: Which new omicron-specific Covid booster should you get?
▼ + stars: | 2022-09-27 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Americans have two options for a new omicron-specific Covid booster shot: Pfizer or Moderna. Pfizer's booster is cleared for anyone 12 and older, while Moderna's booster is for people 18 and older. "People ages 18 years and older may get a different product for a booster than they got for their primary series, as long as it is [Pfizer or Moderna,]" the CDC's website reads. "It's OK to mix and match Moderna and Pfizer," Dr. Ralph Gonzales, associate dean for clinical innovation at UC San Francisco, said at a campus town hall earlier this month. I definitely felt a stronger response with the Moderna — having had Pfizer before — but either combinations are fine."

☆ U.S. FDA clears additional lots of Moderna's Covid booster amid shortage
▼ + stars: | 2022-09-26 | by ( ) www.reuters.com time to read: +1 min

A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File PhotoSept 26 (Reuters) - The U.S. Food and Drug Administration said on Monday it has authorized an additional five batches of Moderna Inc's (MRNA.O) updated Covid booster shots made at a Catalent facility in Indiana, after it deemed them safe for use. Last week, the health regulator had allowed use of ten batches of Moderna's updated booster shots made at the Bloomington, Indiana facility, owned by a unit of Catalent Inc (CTLT.N), which is currently not a part of the company's emergency use authorization. The FDA had earlier said Moderna had requested authorization for additional batches in light of the current supply issues. The U.S. government, which has sent out over 25 million of the COVID-19 booster shots targeting BA.4 and BA.5 subvariants of Omicron, has ordered more than 170 million updated shots for this fall, in preparation for a broad revaccination campaign.

☆ Pfizer CEO tests positive for COVID for a second time
▼ + stars: | 2022-09-24 | by ( ) www.reuters.com time to read: +2 min

Register now for FREE unlimited access to Reuters.com RegisterAlbert Bourla, CEO of Pfizer attends a discussion at the World Economic Forum (WEF) in Davos, Switzerland May 25, 2022. REUTERS/Arnd WiegmannSept 24 (Reuters) - Pfizer Inc (PFE.N) Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. Bourla has received four doses of the COVID vaccine developed by Pfizer and its German partner BioNTech (22UAy.DE). A federal health agency said this week that over 25 million doses of the so-called bivalent shots had been sent out. read moreRegister now for FREE unlimited access to Reuters.com RegisterReporting by Mrinmay Dey in Bengaluru; Editing by Daniel WallisOur Standards: The Thomson Reuters Trust Principles.

☆ Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old
▼ + stars: | 2022-09-23 | by ( Spencer Kimball | ) www.cnbc.com time to read: +2 min

Moderna has asked the Food and Drug Administration to authorize its omicron booster shots for children, the company announced on Friday. The Centers for Disease Control and Prevention, in a document published Tuesday, said it expects children to become eligible for the omicron boosters by mid-October pending authorization by the FDA. Pfizer told the CDC advisory committee earlier this month that it expects to ask the FDA to authorize omicron boosters for children ages 5 to 11 in early October. U.S. health regulators cleared Moderna's omicron boosters for adults earlier this month. There is also concern that the original shots' effectiveness at preventing hospitalization and severe illness is starting to decline.

☆ U.S. CDC expects Omicron COVID boosters for kids by mid-October
▼ + stars: | 2022-09-21 | by ( ) www.reuters.com time to read: +1 min

REUTERS/Hannah BeierSept 21 (Reuters) - The U.S. Centers for Disease Control and Prevention expects COVID-19 vaccine boosters targeting circulating variants of the virus to be available for children aged 5-11 years by mid-October. Register now for FREE unlimited access to Reuters.com RegisterThe CDC said it expects Pfizer-BioNTech's (PFE.N), bivalent vaccine to be available for children aged 5-11 years, and Moderna's (MRNA.O) vaccine for those aged 6-17 years, pending FDA authorization. The Pfizer vaccine is already authorized as a booster dose for children over 12 years of age, while Moderna's bivalent vaccine is authorized for adults. The CDC expects pre-orders for the Pfizer shot to begin for the age group next week. The Moderna vaccine will have the same formulation for children and adults and will not require a separate pre-order period, the CDC said.

☆ U.S. delivers over 25 mln COVID boosters; Moderna's shot in limited supply
▼ + stars: | 2022-09-20 | by ( ) www.reuters.com time to read: +2 min

A nurse fills up syringes with the coronavirus disease (COVID-19) vaccines for residents who are over 50 years old and immunocompromised and are eligible to receive their second booster shots in Waterford, Michigan, U.S., April 8, 2022. Both CVS and Walgreens said they are working with the government to acquire more Moderna doses and have not seen any supply issues for the Pfizer/BioNTech booster. Register now for FREE unlimited access to Reuters.com RegisterIn August, the U.S. Food and Drug Administration authorized Pfizer and Moderna's updated booster shots that target the dominant BA.4 and BA.5 Omicron subvariants, as the country prepares for a broad fall revaccination campaign. It said it expects to ship the 70 million doses by the end of the year, as promised in its contract. The U.S. has ordered more than 170 million updated vaccine booster shots for this fall when all individuals aged 12 and over who have already received the initial doses of the vaccine are being encouraged to receive a booster shot.

☆ China approved a COVID-19 vaccine mist that can be inhaled: the first needle-free booster option
▼ + stars: | 2022-09-05 | by ( Andrea Michelson | ) www.businessinsider.com time to read: +2 min

A COVID-19 vaccine mist has been approved for use as a booster dose in China. The vaccine maker CanSino repackaged its shot as a mist meant to be inhaled. Regulators in China approved a COVID-19 vaccine mist for use as a booster dose, making it the first alternative to injectable vaccines used during the pandemic. Similar to the COVID-19 vaccines used in the US, CanSino's formulation contains pieces of genetic material so the body can recognize the virus. Only time will tell if the mistable COVID vaccine provides enough booster protection to be approved and widely distributed in other countries.

☆ Should You Get Another Covid Booster?
▼ + stars: | 2022-03-29 | by ( ) www.nytimes.com time to read: +12 min

to authorize a second booster shot of its vaccine — that is, a fourth dose — for people aged 65 and older. Two days later, Moderna followed suit, but with a broader request to authorize a second booster for all adults over 18. The agency said on Tuesday that adults aged 50 and older could opt for a second booster shot of the vaccines made by Pfizer-BioNTech or Moderna, to be given at least four months after the first booster of any authorized or approved Covid vaccine. A second booster would be the third shot for those who received one dose of the Johnson & Johnson vaccine and a booster shot of an mRNA vaccine. In fact, other data from Israel suggests that a second booster has only marginal benefits in healthy young people.

☆ Rep. Marie Newman and her husband are packing their stock portfolio with COVID-19 vaccine makers and other pandemic-sensitive companies
▼ + stars: | 2021-04-21 | by ( Kimberly Leonard | Warren Rojas | ) www.businessinsider.com time to read: +11 min

Democratic Rep. Marie Newman's husband has an active stock portfolio. Jim Newman, chief operating officer at Figo Pet Insurance, bought and sold stock in companies that either soared or sputtered during the pandemic, including Pfizer and Moderna, the companies behind the nation's two leading COVID-19 vaccines. Financial disclosures show Jim Newman sold up to $65,000 in Moderna stock on January 2. By February, he turned his interest to Pfizer, twice trading as much as $15,000 worth in the company's stock shares that month. For instance, Newman sold as much as $250,000 in Netflix stock in January, as much as $50,000 in Apple stock in February, and as much as $50,000 in Salesforce stock in January.

☆ 23 Black leaders who are shaping history today
▼ + stars: | 2021-02-01 | by ( Courtney Connley | ) www.cnbc.com time to read: +39 min

Following the lead of trailblazers throughout American history, today's Black history-makers are shaping not only today but tomorrow. —Cory StiegRosalind Brewer, 58, Walgreens' next CEO and only Black woman to currently lead a Fortune 500 firmWalgreens' next CEO Rosalind Brewer. When she steps into this new role, she will be the only Black woman currently leading a Fortune 500 firm, and just the third Black woman in history to serve as a Fortune 500 CEO. "When you're a Black woman, you get mistaken a lot," she said during a 2018 speech at her alma mater, Spelman College. —Tom Huddleston Jr.Jason Wright, 38, first Black president of a National Football League teamWashington Football Team president Jason Wright.

Persons: Shirley Chisholm, John Lewis, Maya Angelou, Mary Ellen Pleasant, Kamala Harris, Gene Kim, Harris, Shyamala Gopalan Harris, Shyamala, —, — Cory Stieg Rosalind Brewer, Rosalind Brewer, Ursula Burns, Mary Winston, Brewer, Kimberly, Clark, she's, — Courtney Connley, Kizzmekia, Corbett, Kizzmekia Corbett, Anthony Fauci, Fauci, Dr, — Cory Stieg Victor J, Glover , Jr, Victor Glover, Amanda Gorman, Joe Biden, Gorman, Abraham Lincoln, Martin Luther King Jr, Lady Jill Biden, Robert Frost, Oprah, Angelou, — Jennifer Liu, Amanda Gorman's, Raphael Warnock, Georgia's, Kelly Loeffler, Warnock, Ebenezer Baptist Church —, — Abigail Johnson Hess Rashida Jones, Rashida Jones, Jones, Kristen Welker, Carole Simpson, Nicolle Wallace's, Dorothy Tucker, Brown, — Taylor Locke Sandra Lindsay, Sandra Lindsay, Lindsay, She's, I'm, Jade Scipioni Nicholas Johnson, Princeton's, Nicholas Johnson, Princeton University's, Johnson, William Massey, — Abigail Johnson Hess Cynthia, Cynt, Marshall, Cynthia Marshall, Cynt Marshall, George Floyd, Marshall —, Mark Cuban, Scipioni, Cynthia Marshall's, Dallas Mavericks Cori Bush, Missouri's, Missouri, Cori Bush, Michael Brown, Ferguson, William Lacy Clay Jr, Bush, Essence.com, I've, he's, Louis, Clay, — Jennifer Liu Alicia Boler Davis, Amazon's, Jeff Bezos Alicia Boler Davis, Alicia Boler Davis, Boler Davis, Jeff Bezos, alums, Jennifer Liu, Noah Harris, Harvard Noah Harris, Harvard's, It's, we've, Fentrice Driskell, Du Bois, — Abigail Johnson Hess, Harvard Mellody Hobson, Mellody Hobson, Ariel Investments, Hobson, — Courtney Connley Sydney Barber, Sydney Barber, Barber, Ms, Janie Mines, wasn't, Mines, Jesse Collins, Collins, Indiewire, " Collins, Jennifer Liu Nia DaCosta, Nia DaCosta, Marvel, DaCosta, Nora Ephron, Jordan Peele, Peele, — Tom Huddleston Jr, Aicha Evans, Zoox, Evans, Jason Wright, Wright, He's, Dan Snyder, — Emmie Martin Dana Canedy, Dana Canedy, Simon, Simon & Schuster, Dana Canedy's, Canedy, Denzel Washington, Alicia Adamczyk, Schuster Bozoma Saint John, Saint John, Beyonce, Kanye West, Nicki Minaj, Michael Jackson, — Courtney Connley Cheick Camara, Ermias Tadesse, Cornell University's, Cheick Camara, Ermias Organizations: CNBC, White, South, Latina, Howard University, Alpha Kappa Alpha Sorority, Inc, Democrat, United States Senate, U.S, Walgreens, Fortune, Starbucks, Walgreens Boots Alliance, Xerox, Bed, Sam's, Walmart, Nonwovens, Spelman College, Moderna, National Institute of Allergy, National Urban League, FDA, Vaccine Research, University of North, Space Station, NASA, Capitol, LA, Poet, Harvard, Georgia, Black, Morehouse College cum, Ebenezer Baptist Church, United, MSNBC, University of Missouri's School of Journalism, NBC, ABC News, National Association of Black Journalists, Jewish Medical Center, Northwell, Long, Pfizer, Pew Research Center, Princeton, Massachusetts Institute of Technology, NBA Dallas Mavericks, Dallas Mavericks, NBA, Mavericks, Congress, Senate, Democratic, Green New Deal, General Motors Institute, GM, Amazon, Employees, Amazon's, Ariel Investments, Ariel, Financial Planning's Diversity, Princeton University, JPMorgan, Lucas Family Foundation, Hobson College, Naval, U.S . Naval Academy, U.S . Naval, Naval Academy, Academy, Super, Super Bowl, Jesse Collins Entertainment, ViacomCBS Cable Networks, BET, CMT, Comedy Central, MTV, Paramount Network, VH1, Marvel, Marvel Studios, Marvel Universe, Tribeca, Wall Street, George Washington University, Intel, Financial, Automotive News, National Football League, Washington Football, Washington Football Team, National Football, NFL, Atlanta Falcons, Cleveland Browns, Arizona Cardinals, University of Chicago, McKinsey & Company, Washington, Morning, Simon &, New York Times, Jordan, Crown Publishers, New Yorker, Netflix, Saint, Longtime, Endeavor, Uber, Apple, PepsiCo, BlackGen Capital, Cornell, BlackGen Locations: United States, Oakland , California, India, America, White, California, University of North Carolina, Chapel, Los Angeles, Georgia's, Savannah , Georgia, Ebenezer, Long, New York, Queens , New York, Jamaica, Princeton, Montreal, Canada, Spring, Missouri, Louis, St, Detroit, Hattiesburg , Mississippi, Florida, Chicago, U.S, Lake Forest , Illinois, Sydney, mull, Senegal, Zoox, Charlottesville , VA

☆ Dolly Parton's morning routine: 'I’m a very early riser. I’m almost always up for good around 3 a.m.'
▼ + stars: | 2020-12-08 | by ( Taylor Locke | ) www.cnbc.com time to read: +3 min

So, how does Parton find the time to do it all? "I'm a very, very, very early riser," Parton told RuPaul Charles in an interview for Marie Claire. "I'm always, almost always up for good around 3 a.m."Don't miss: The best credit cards for building creditTypically, she goes to bed "pretty early, but I'm up and down," she said. The first thing Parton does when she wakes up is pray. "But usually, if I'm on the job, I'll take a little power nap" during the day, Parton said.

Search resuls for: "The Moderna"

20 mentions found